Cargando...
Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
New biomarkers of IgA nephropathy (IgAN) are needed for non-invasive diagnosis and appropriate treatment. There is emerging evidence that galactose deficient IgA1 (Gd-IgA1) is a pivotal molecule in the pathogenesis of IgAN. However, few studies have investigated the role of Gd-IgA1 as a biomarker in...
Gardado en:
| Publicado en: | J Clin Med |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7694202/ https://ncbi.nlm.nih.gov/pubmed/33158064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9113549 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|